Cas 1109293-83-5,N-hydroxy-4-{5-[4-(2-methyl-5-morpholin-4-ylthiazol-4-yl)phenoxy]pentyloxy}benzamidine

1109293-83-5

Post Buying Request

Basic information

Product Name: N-hydroxy-4-{5-[4-(2-methyl-5-morpholin-4-ylthiazol-4-yl)phenoxy]pentyloxy}benzamidine
Synonyms: N-hydroxy-4-{5-[4-(2-methyl-5-morpholin-4-ylthiazol-4-yl)phenoxy]pentyloxy}benzamidine
CAS NO:1109293-83-5
Molecular Formula:
Molecular Weight: 496.63
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-hydroxy-4-{5-[4-(2-methyl-5-morpholin-4-ylthiazol-4-yl)phenoxy]pentyloxy}benzamidine(CAS DataBase Reference)
NIST Chemistry Reference: N-hydroxy-4-{5-[4-(2-methyl-5-morpholin-4-ylthiazol-4-yl)phenoxy]pentyloxy}benzamidine(1109293-83-5)
EPA Substance Registry System: N-hydroxy-4-{5-[4-(2-methyl-5-morpholin-4-ylthiazol-4-yl)phenoxy]pentyloxy}benzamidine(1109293-83-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1109293-83-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1109293-83-5 Suppliers

Recommended suppliers

1109293-83-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1109293-83-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,9,2,9 and 3 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1109293-83:
(9*1)+(8*1)+(7*0)+(6*9)+(5*2)+(4*9)+(3*3)+(2*8)+(1*3)=145
145 % 10 = 5
So 1109293-83-5 is a valid CAS Registry Number.

1109293-83-5Upstream product

1109294-38-3 4-{5-[4-(2-methyl-5-morpholin-4-ylthiazol-4-yl)phenoxy]pentyloxy}benzonitrile

1109293-83-5Downstream Products

1109293-83-5Relevant academic research and scientific papers

NOVEL BENZAMIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OSTEOPOROSIS COMPRISING THE SAME

-

Page/Page column 87-89, (2009/03/07)

The present invention relates to novel benzamidine derivatives, a process for the preparation thereof and a pharmaceutical composition for preventing or treating osteoporosis comprising the same. The benzamidine derivatives of the present invention effect

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1109293-83-5